XORTX Therapeutics XRTX
NASDAQ XRTX
$1.70 0.00 (-0.28%)
As of: Sep 30, 2026 · 10:23 AM EDT

XORTX Therapeutics (XRTX) Current Assets (2020 - 2026)

Updated

XORTX Therapeutics' Current Assets came in at $2.44 million for the quarter ended Jun 30, 2026, up 92.7% from $1.26 million a year earlier and up 227.4% from the prior quarter.

Analysis

XORTX Therapeutics (XRTX) Current Assets (2020 - 2026) Analysis & Trends

As of Dec 31, 2025, XORTX Therapeutics' Current Assets was $1.26 million, down 52.9% from the prior year.

  • Current Assets has declined in each of the last four years, with a five-year compound annual growth rate of -3.9% (years ended Dec 2020 to Dec 2025).
  • Going back by year, Current Assets was $2.68 million in the year ended Dec 31, 2024 (-34.2%), $4.07 million in the year ended Dec 31, 2023 (-62.7%), $10.9 million in the year ended Dec 31, 2022 (-31.5%) and $15.91 million in the year ended Dec 31, 2021 (+936.7%).
  • The figure for the quarter ended Jun 30, 2026 represents the highest quarterly Current Assets since the quarter ended Dec 31, 2024.
  • Year-over-year, Current Assets increased in 1 of the last eight quarters, with an average decline of 34.2%.
  • The fastest year-over-year change in Current Assets over five years came in the quarter ended Dec 31, 2021 (growth of 914.7%), and the weakest in the quarter ended Mar 31, 2026 (a decline of 64.6%).
  • Business Quant data shows XRTX's Current Assets at $744,416 (quarter ended Mar 31, 2026), $1.26 million (quarter ended Dec 31, 2025) and $1.36 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 59.77 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 33.67 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 36.68 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 27.35 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 27.97 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.96 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 13.95 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 41.36 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 12.54 Bn
10 XORTX Therapeutics 1.62 Mn -1.68 Mn - 2.44 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.44 Mn
Mar 31, 2026 744,416.00
Dec 31, 2025 1.26 Mn
Sep 30, 2025 1.36 Mn
Jun 30, 2025 1.26 Mn
Mar 31, 2025 2.10 Mn
Dec 31, 2024 2.68 Mn
Sep 30, 2024 2.41 Mn
Jun 30, 2024 3.36 Mn
Mar 31, 2024 4.66 Mn
Dec 31, 2023 4.07 Mn
Sep 30, 2023 5.23 Mn
Jun 30, 2023 6.38 Mn
Dec 31, 2022 10.87 Mn
Dec 31, 2021 16.00 Mn
Dec 31, 2020 1.58 Mn
API Access

XORTX Therapeutics Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=XRTX&period=max&api_key=YOUR_API_KEY